| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $392K | -73.9% |
| R&D Expense | $28.6M | +16.1% |
| SG&A Expense | $31.1M | -4.2% |
| Operating Income | -$59.3M | -6.7% |
| Pre-tax Income | -$52.3M | +3.4% |
| Income Tax | $0 | — |
| Net Income | -$52.3M | +3.4% |
| EPS (Basic) | -$0.74 | +3.9% |
| EPS (Diluted) | -$0.74 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.0M | -39.7% |
| Current Assets | $109.6M | -16.6% |
| Total Assets | $144.0M | -7.2% |
| Current Liabilities | $11.5M | +64.1% |
| Total Liabilities | $56.2M | +144.5% |
| Stockholders' Equity | $87.8M | -33.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.8M | +17.1% |
| Capital Expenditures | $40K | -96.7% |
| Investing Cash Flow | -$2.6M | +97.1% |
| Financing Cash Flow | $30.5M | — |
| Free Cash Flow | -$45.8M | +18.8% |
| +3.9% |